Fwd: What do Pondimin, Redux,Seldane, Posicor, Duracht, Hismanal, Raxar, Rezulin, Propulsid, Lotronex, Raplon, and Baycol all have in common?

[Guest guest]

SSRI-Research , JustSayNo wrote:

What do Pondimin, Redux,Seldane, Posicor, Duracht, Hismanal, Raxar,

Rezulin,

Propulsid, Lotronex, Raplon, and Baycol all have in common?

 

Answer: All are drugs that the FDA pulled off the market within the

last few

years that were fraudulently approved by this criminal Agency where

corruption runs rampant.

 

I just watched a great documentary on the Public Broadcasting System's

" Frontline " program titled " Dangerous Prescription " about how the FDA

is

killing Americans in unprecedented numbers in the past 5 years due to

criminality within the Agency.

 

http://www.pbs.org/wgbh/pages/frontline/shows/prescription/hazard/

 

Congressional Pharma Stooges such as Senator Dick Durbin (S.722

Dietary

Supplement Safety Act) and Congressmen Davis, Waxman, and Dingle (HR

3377)

have a lot of nerve claiming that dietary supplements pose a threat

in our

society and that we need " FDA to reign them in " when we have this

heavily

documented level of corruption at the FDA which is clearly serving as

a

Trade Association for the pharmaceutical industry.

 

Call your Congressman today via 202-225-3121 and complain. Tell them

to tune

in this PBS documentary on the web on Sunday.

 

On Sunday, people world wide can view this show in its entirety on at

the

URL above, and I encourage all of you on the IAHF list to, and to

encourage

your elected officials to also- because instead of engaging in witch

hunts

attacking safe dietary supplements, the criminals who work for the

world's

FDA's need to be reigned in. Some should be imprisoned for approving

poisons

such as these.

 

Former FDA drug reviewers who quit due to total disgust at how their

reports

were censored, and altered, and how they were pressured to change

reports to

make them more favorable for approval were interviewed regarding the

fraudulent approval of such dangerous drugs as Dexfenfluoramine,

Pondamin,

Raxar and many others.

 

Here is an interactive Chart showing a dozen drugs that were

fraudulently

approved by the FDA, then removed from the market between 1997 and

2001. The

chart names the drug, the manufacturer, when there were approved,

what the

drug was prescribed for, the adverse effects, and the date the drug

was

finally withdrawn from the market.

 

http://www.pbs.org/wgbh/pages/frontline/shows/prescription/etc/dozen.h

tml

 

Here is information from the PBS website about this interesting

program:

 

SAFE AND EFFECTIVE?

How good is America's drug safety system? Since 1997, more than a

dozen

prescription drugs have been taken off the market due to serious side

effects -- in some cases after hundreds of injuries and even deaths

have

occurred. Is the Food and Drug Administration, which is responsible

for

approving and monitoring the safety of the medications we take, up to

the

task? Here are excerpts from FRONTLINE's interviews with the FDA's

Steven

Galson and Paul Seligman, Public Citizen's Sidney Wolfe, and Raymond

Woosley

of the University of Arizona.

 

HOW INDEPENDENT IS THE FDA?

http://www.pbs.org/wgbh/pages/frontline/shows/prescription/hazard/inde

penden

t.html

Is the FDA too close to the industry it regulates? Critics argue that

industry funding of the drug review and approval process gives

pharmaceutical companies, and their lobbyists, too much influence over

decision-making and policy. To address these issues, in excerpts from

FRONTLINE's interviews, are Public Citizen's Sidney Wolfe, the FDA's

Steven

Galson, the University of Arizona's Raymond Woosley, and

pharmaceutical

industry lobbyist John Kelly.

 

INTERVIEW: LEO LUTWAK, MD

http://www.pbs.org/wgbh/pages/frontline/shows/prescription/interviews/

lutwak

..html

" The FDA is wholly dependent on trust -- on trusting [that] the

company is

providing all the truth all the time, " says Leo Lutwak, a retired FDA

drug

reviewer specializing in obesity. Dr. Lutwak was the chief medical

reviewer

for weight-loss drugs and was at the center of the Fen Phen

controversy. In

this interview, Dr. Lutwak recalls the role he played in the review

of Redux

and provides insight into the sequence of events that led to the

recall of

this drug. (Since the time this interview was conducted, Lutwak has

been

retained by plaintiff's counsel in the ongoing litigation surrounding

these

drugs.)

 

INTERVIEW: MICHAEL ELASHOFF, PhD.

http://www.pbs.org/wgbh/pages/frontline/shows/prescription/interviews/

elasho

ff.html

 

" I think it was pretty well understood, " say former FDA scientist

Michael

Elashoff, " that if you were advocating turning a drug down --

particularly

if it was from a large pharmaceutical company -- that that wouldn't

be good

for your career. " A drug reviewer for the FDA from 1995 to 2000,

Elashoff

says he was marginalized within the agency after he voiced his

concerns

about a new flu drug called Relenza. Here, Elashoff speaks out about

the

culture of the FDA's drug approval process.

 

INTERVIEW: STEVEN GALSON, MD

http://www.pbs.org/wgbh/pages/frontline/shows/prescription/interviews/

galson

..html

 

" We think we can run a high-quality independent program, regardless

of the

source of the resources, " says the FDA's Steven Galson, acting

director of

the Center for Drug Evaluation and Research, " as long as, of course,

the

resources aren't linked to performance goals that are going to

interfere

with our independence. " In this interview, Galson discusses the FDA's

drug

safety system and explains how the Prescription Drug User Fee Act

helps the

FDA.

 

INTERVIEW: PAUL SELIGMAN, MD, MPH

http://www.pbs.org/wgbh/pages/frontline/shows/prescription/interviews/

seligm

an.html

" The fundamental point, " says Seligman, director of the FDA's Office

of Drug

Safety, " is that no drug -- even having gone through this long period

of

development, testing, and review -- is 100 percent safe. " Seligman

explains

how his office handles adverse-event reports from pharmaceutical

companies

and through the MedWatch system, and discusses various areas in which

the

agency's drug safety program could be improved.

 

International Advocates for Health Freedom

POB 10632 Blacksburg VA 24062 USA

http://www.iahf.com; http://iadsa-exposed.tripod.com

800-333-2553 N.America

540-961-0476 World

--- End forwarded message ---